Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort
Jeanne Feuerstein1, Ethan Brown2, Lana Chahine3, Caroline Gochanour4, David-Erick Lafontant4, Micah Marshall4, Tanya Simuni5, Daniel Weintraub6, Amy Amara1
1University of Colorado School of Medicine, 2Neurology, University of California, San Francisco, 3Neurology, University of Pittsburgh, 4University of Iowa CTSDMC, 5Northwestern University Feinberg School of Medicien, 6Psychiatry, University of Pennsylvania
Objective:
Examine baseline clinical and biological characteristics of participants with polysomnography-confirmed REM Sleep Behavior Disorder (RBD).
Background:
RBD is an early manifestation of underlying synucleinopathy with progression to a clinical synucleinopathy in over 70%. Prevalence of synuclein aggregation in cerebrospinal fluid (CSF) and dopaminergic deficit on DaT scans (D+) in individuals with RBD is not well established. We compare baseline biological and clinical characteristics in RBD between groups distinguished by presence (S+) or absence (S-) of synuclein aggregates.
Design/Methods:
290 RBD participants were enrolled in a multicenter prospective longitudinal cohort study, the Parkinson Progression Markers Initiative. Aggregated alpha-synuclein was assessed in CSF using seed amplification assay (SAA) and dopaminergic dysfunction was assessed using SPECT scan. Baseline data were summarized and S+ and S- groups were compared. Three participants had MSA-like SAA and were excluded from the comparison.
Results:
At baseline, mean age overall was 67.8 (6.3) years and 79% were male. 72% were SAA+ and 48% were D+ (<75% of age/sex-expected lowest putamen SBR). S+ participants were more frequently hyposmic (UPSIT<15%, 89% vs 20%) and D+ (54% vs 32%). Self-reported depression and anxiety were more prominent in the S- group (MDS-UPDRS I.3, Geriatric Depression Scale, MDS-UPDRS 1.4, State-Trait Anxiety Inventory). Motor symptoms (MDS-UPDRS III) and cognitive assessments (MoCA) were not significantly different between groups.
Conclusions:
We present biological and clinical data of a large RBD cohort. Nearly three-quarters were S+ and approximately half were D+. This is consistent with the hypothesis that alpha-synuclein aggregation precedes dopaminergic deficit detectable on DaT scan.
The S+ cohort’s biological profile identified hyposmia and presence of dopaminergic deficit, while the S- cohort’s profile identified more self-reported mood disturbances. Longitudinal biological and clinical monitoring in people with RBD will define predictors and timelines of progression and provide opportunities for future interventions.
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.